The Sklar Fellowship in Psychiatric Genetics and Neuroscience
The goal of the Sklar Fellowship was to offer an opportunity for advanced study and research in psychiatric genetics and neuroscience with the goal to serve as a bridge between completion of clinical training and the start of an independent research career.

Current Sklar Fellows
Rachel Asher
Rachel Asher, M.D., received her medical degree from the University of Illinois College of Medicine and graduated from Brigham and Women’s Hospital Psychiatry Residency Program. As Sklar Fellow, she is working with Steve Hyman, Ben Neale, Kerry Ressler, Stanley Center scientists, and the Ó³»´«Ã½ Ethics Committee to develop a research initiative (Neurobridge) to facilitate interdisciplinary integration across the neuroscience-neuroethics-society interface for the purposes of improving translation, impact, and alignment in neuroscience. By utilizing reflexive metascience, Rachel aims to collaboratively integrate qualitative, quantitative, and artistic data on diverse lived experiences of academic and non-academic community members to design solutions for psychological, sociocultural, political, and epistemic dynamics which may pose barriers to the development of healthier, more translationally effective research ecosystems.

Evan Giangrande
Evan Giangrande, Ph.D., received his doctorate in clinical psychology with a concentration in quantitative psychology from the University of Virginia, working on longitudinal dynamics of gene-environment interplay across cognitive development. He then pursued a doctoral internship in clinical psychology in adult psychopathology at McLean Hospital. As a Sklar Fellow, he is working with Ben Neale and Jordan Smoller, leveraging genomics and longitudinal electronic health record data to examine the etiology, course, and outcomes of psychotic disorders. In this work, he has applied machine learning algorithms to identify psychotic disorder subtypes characterized by heterogeneous trajectories of illness course, and examined genetic influences on variation in clinically relevant schizophrenia outcomes including global functioning and hospitalization burden.

Yong Kim
Yong Kim, M.D., Ph.D., earned his medical degree and doctoral degree in genetics and epigenetics from the University of Pennsylvania, where he investigated 3D genome organization in circadian biology. Following his psychiatry residency at Brigham and Women’s Hospital, he joined McLean Hospital as an instructor in psychiatry, where he currently treats patients in its Psychosis Disorders Inpatient Units. As a Sklar Fellow, he is continuing his research with Steve McCarroll, focusing on elucidating the molecular mechanisms orchestrating the synaptic neuron-astrocyte program (SNAP) that underlies genetic risk for schizophrenia.
Past Sklar Fellows
Joshua Salvi, M.D., Ph.D.
Psychiatrist, Massachusetts General Hospital
Fellowship Project: Exploring the connection between patterns of structured movement variance and novel genomic findings that impact clinical outcomes in obsessive-compulsive disorder.
Baker group, co-mentored by Kerry Ressler, 2021 - 2022
Whitney McFadden, M.D.
Psychiatrist, Marvin Behavioral Health
Fellowship Project: Identifying the single cell transcriptome of brain organoid models from individual patients with schizophrenia.
Church group, co-mentored by Jordan Smoller, 2020 - 2021
Baktash Babadi, M.D., Ph.D.
Psychiatrist, Massachusetts General Hospital
Fellowship Project: Relating the visual deficits in schizophrenia to the dysfunction of the underlying neural circuits through a combination of computational, psychophysical, and neuroimaging approaches.
Holt & Tootell group, co-mentored by Dost Öngür, 2019 - 2021
Robert Mealer, M.D., Ph.D.
Assistant Professor of Psychiatry, Oregon Health & Science University
Fellowship Project: Elucidating the role of a manganese transporter in the etiology of schizophrenia, with the goal of identifying disease biomarkers and novel therapeutics.
Smoller & Scolnick group, 2017 - 2020
Anthony Deo, M.D., Ph.D.
Assistant Professor, Rutgers Robert Wood Johnson Medical School
Fellowship Project: Analyzing neurodevelopmental pathology in schizophrenia and in utero cannabis exposure using a human IPSC forebrain organoid model.
Arlotta group, 2017 – 2019
Michael Murphy, M.D.
Assistant Professor, Harvard Medical School
Fellowship Project: Utilizing electroencephalography to measure the activity of the brain during waking, sleep, and anesthesia.
Öngür group, 2016 – 2017
Thomas McCoy, M.D.
Associate Professor of Psychiatry, Massachusetts General Hospital
Fellowship Project: Developing a high-throughput computational approach to deep, multi-dimensional psychiatric phenotyping.
Perlis group, 2015 – 2016
, M.D., Ph.D.
Associate Professor of Psychiatry, Harvard Medical School; Core Member of the Ó³»´«Ã½
Fellowship Project: Defining the RNA transcriptome in individual cells of the human brain (Drop-seq) to establish a foundation for understanding how molecular perturbations lead to the pathophysiology found in patients with psychiatric disease.
McCarroll group, 2014 – 2016